ArticleNanomaterials (Basel, Switzerland)2022
Mussel-Inspired Surface Modification of α-Zirconium Phosphate Nanosheets for Anchoring Efficient and Reusable Ultrasmall Au Nanocatalysts.
Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 12 citations in OpenAlex.
- Synthesis and Catalytic Activity for 2, 3, and 4-Nitrophenol Reduction of Green Catalysts Based on Cu, Ag and Au Nanoparticles Deposited on Polydopamine-Magnetite Porous Supports.Nanomaterials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
Abstract
The shortage of powerful functionalities on scalable α-zirconium phosphate (ZrP) materials blocks the facile preparation of highly dispersed and immobilized metal nanocatalysts. We herein present a mild and facile mussel-inspired strategy based on polydopamine (PDA) for the surface modification of ZrP, and hence, the generation of powerful functionalities at a high density for the straightforward reduction of chloroauric acid to Au nanoparticles (AuNPs) and the immobilization of AuNPs. The resulting ternary ZrP@PDA/Au exhibited ultra-small AuNPs with a particle size of around 6.5 nm, as estimated based on TEM images. Consequently, the ZrP@PDA/Au catalyst showed significant activity in the catalytic conversion of 4-nitrophenol (4NP) to 4-aminophenol (4AP), a critical transformation reaction in turning the hazard into valuable intermediates for drug synthesis. The PDA was demonstrated to play a critical role in the fabrication of the highly efficient ZrP@PDA/Au catalyst, far outperforming the ZrP/Au counterpart. The turnover frequency (TOF) achieved by the ZrP@PDA/Au reached as high as 38.10 min
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.